1. Allegra L, Grassi C, Grossi E, Pozzi E. Ruolo degli antidiotici nel trattamento delle riacutizza della bronchite cronica. Ital J Chest Dis. 1991; 45: 138–48.
2. Saint S, Bent S, Vittinghof E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analisis. JAMA. 1995; 273: 957–60.
3. Anthonisen NR, Manfreda J, Warren CP et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196–204.
4. Peifer G, Veyssier P, Zuck P. Efficacy of levofloxacin (LVF) in the treatment of acute exacerbations of chronic bronchitis (AECB) in patients with risk factors. Europ Resp J 2003; 22 (Suppl. 45): 3558A.
5. Charlene Laino: «Antimicrobial-Resistant Streptococcus pneumoniae Isolated From Patients With Acute Bacterial Exacerbation of Chronic Bronchitis» the 100th International Conference of the American Thoracic Society. ORLANDO, FL May 26, 2004. Abstract A47 Poster E28.
6. Global Strategy for the Diagnosis, Managment and Prevention of Chronic Obstructive Pulmonary Disease. 2007.
7. Grossman RF. JAMA 1997; 278: 901–4.
8. Синопальников А.И. и др. Рос. мед. вестн. 2006; 12: 4–18.
9. Дворецкий Л.И. Инфекционное обострение хронической обструктивной болезни легких: от своевременной диагностики к адекватной антибактериальной терапии. Cправ. поликлин. врача 2008; 9: 28–32.
10. Masterton RG, Burley CJ. Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis International Jornal  Antimicrobial  Agents 2001; 18: 503–13.
11. Lode Н, Eller J, Linnhoff A et al. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval Eur Respir J 2004; 24: 947–53.
12. Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165(17): 1992–2000.
13. Martinez JA, Horcajada JP, Almela M еt al. Addition of macrolide to a beta-lactam-baseв empirical antibiotic regimen is associated with lower inhospitality mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389–95.
14. File TM, Sergeti G, Player R et al. A multicеnter randomised study comparing the efficacy and safety of intravenous and or oral levofloxacin versus ceftriaxon and or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agent Chemother 1997; 41: 1965.
15. Norrby SR, Petermann W, Willcox PA et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis 1998; 30: 397–404.
16. Kahn JB, Wiesinger A, Olson WH et al. Levofloxacin vs ceftriaxone sodium and erytromycin in the treatment of patients with community-acquired pneumonia at high risk of mortality Abstracts of 7th International Symposium on New Quinolones. Edinburg, UK, 2001.
17. Ramires JA. Switch therapy in adult patients with pneumonia. Clin Pulm Med 1995; 2: 327–33.
18. Meehan TP, Fine MJ, Krumholz HM et al. Quality of care process and outcomes in elderly patients with pneumonia JAMA 1997; 278: 2080.
19. Houck PM, MacLehose RF, Niederman MS et al. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 Western States: 1993, 1995, and 1997. Chest 2001; 119: 1420–6.
20. European Medicines Agency, press-release: EMA recommends restricting the use of oral moxifloxacin-containing medicines. London, 24 July 2008 Doc. Ref. EMEA/CHMP/382927/2008, www.emea.europa.eu.
21. Христолюбова В.И., Волкова Л.И. Ошибки в диагностике и лечении пневмоний в поликлинических условиях. Тер. арх. 2005; 1: 45.
22. Дворецкий Л.И., Яковлев С.В. Ошибки в антибактериальной терапии инфекций дыхательных путей в амбулаторной практике. Леч. врач 2003; 8.
23. Юдина Л.В. Тактика ведения больных внебольничной пневмонией. Учимся на чужих ошибках. Здоровье Украины 2007; 2: 19.
24. Cabana MD, Rand CS, Power NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458–65.
25. Синопальников А.И.. Барьеры на пути внедрения клинических рекомендаций по лечению внебольничной пневмонии: незнание, упрямство или беспечность? Здоровье Украины. 2007; 7: 49.
26. Рачина С.А., Козлов С.Н., Иделевич Е.Я. и др. Представления врачей поликлиник об этиологии и тактике лечения внебольничной пневмонии в амбулаторных условиях. Пульмонология 2004; 2: 6–12.